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BisphenolA (BPA) is active in inmaur AP ratuterotrphicasa when evduatedusingeitherthe
oral or the subcutaneous (sc) injection routes ofeposure (de daily ta of400-800
mg/kg BPA). Prmatue vaginal opening was sen for 8 of 14 animals eposed to 600 and 800
nm/kg BPAby sc injection.Vaginalopenngwas notproducedbyBPAin the gavagestudies. Thes
results are consistentwith thoseofDoddsand Lawson [Nawue 137:96 (1936)1 whofoundthat BPA
induces persistentvain comnfication inovariectomized ratsexposdtothe twice-dailyinjections
of85mg/kgBPA(totldailydose 170mg/kg), buttheyconflictwiththereportedinctivityofBPA
in the imm mouseuterorophicaay. Theuterotroplicacvityofdiehilbestrol inthe rat is
also estabbished (0.04 mg/kg/day for three days). Key word bisphenol A, endocrine, estrogen,
uterus. EnvironHelthPeirpet106:719-720(1998). [Online 14 October 19981
htp://e4rnael.niehs.nih.gov/docs/1998/106p719-720ashby/abstra html
Despite extensive interest in the endocrine
toxicity ofbisphenol A (BPA) to mammals
(1-5), only one report of its activity in the
rodent uterotrophic assay exists (4). In that
study, Coldham et al. (4) exposed immature
(18-day-old) CFLP mice to 0.05, 0.5, and 5
mg BPA per mouse by subcutaneous (sc)
injection on 3 successive days. The 5 mg dose
of BPA was toxic, and the treated mice were
withdrawn from the study. No uterotrophic
activity was observed for the two lower dose
levels, and it was concluded that BPA was
inactive in the mouse uetrotrophic assay. This
condusion is important, given that reliance is
currently placed on the rat/mouse uterotroph-
ic assay as a primary screen for estrogens. We
therefore decided to evaluate this chemical in
the immature rat uterotrophic assay with a
view to establishing ifit is inactive in this assay
usingboth species ofrodent.
Materials and Methods
BPA was obtained from Aldrich Chemical
Company (Poole, Dorset, UK) and diethyl-
stilbestrol (DES) from Sigma Chemical
Company (Poole, Dorset, UK). The vehicle,
arachis oil, was as previouslydescribed (6).
Immature female Alpk:AP rats (21-22
days old), with body weights in the range
38-48 g, were obtained from the breeding
unit at Zeneca, Alderley Park. Animals were
housed in wire mesh cages with solid bot-
toms. Humidity was controlled and a 12
hr/12 hr light/dark cycle was maintained.
Animals were weaned on R&M no. 1 diet at
19-21 days old and maintained on R&M
no. 3 diet from 21 days onward (both diets
obtained from Special Diet Services Ltd.,
Witham, Essex, UK). Diet and water were
available ad libitum. All animals were accli-
matized for 24 hr before being dosed.
The uterotrophic activities of BPA and
DES were evaluated in three separate experi-
ments using the test protocol described earlier
(6). The test agents were dissolved (DES) or
homogeneously suspended (BPA) (6) in
arachis oil and dosed byeither oral gavage or
sc injection. The dosing volume for both
routes ofexposure was 5 ml/kg bodyweight.
Animals received three daily doses ofthe test
compound andwerekilled byan overdose of
Fluothane (Zeneca Pharmaceuticals) 24 hr
after the final dose. The dose levels shown
in Table 1 are the daily dose levels.
Presence or absence ofvaginal opening was
recorded at the time of death. Uteri were
excised, trimmed free of fat, pierced, and
blotted to remove excess fluid. The body of
the uterus was cut just above its junction
with the cervix and at the junction of the
uterine horns with the ovaries. The uterus
was then weighed (wetweight). Uterine dry
weight was also determined by drying the
uteri at 70°C for 24 hr before reweighing
(6). DES was used as positive control agent,
and each study was accompanied by a vehi-
cle (negative) control group. Animal group
sizes are shown in Table 1. Changes in the
weight of wet and dry uteri were assessed
for statistical significance using a two-tailed
Student's t-test.
Results and Discussion
BPA gave a positive uterotrophic assay
response when administered to rats by either
oral gavage or sc injection (Table 1). The
magnitude ofthese responses was similar for
each route ofadministration, and increases
in both wet and dry uterus weights were
observed. Prematurely opened vaginas were
observed for some ofthe animals in the top
two BPA dose level groups (sc injection), an
event not encountered to date among more
than 450 control animals (using either route
of exposure; data not shown). The present
data for BPA are consistent with the report
by Dodds and Lawson (1) that it induces
persistent estrus in ovariectomized rats. In
those studies a total dose of 100 mg ofBPA
was administered per rat, as twice daily sc
injections for 3 days (assuming the rats
weighed about 200 g, the daily dose ofBPA
was about 170 mg/kg).
The positive control agent for the pre-
sent experiments, DES, gave a positive
uterotrophic response using both routes of
administration, and vaginal opening was
observed for some DES animals in each
experiment conducted (Table 1). This
activity ofDES in the rat uterotrophic assay
is consistent with its similar activity in the
mouse uterotrophic assay (2').
The top dose levels of BPA used in the
present experiments gave no dinical signs of
toxicity or effects on body weight, and higher
dose levels could clearly have been adminis-
tered. A detailed dose-response relationship
for the activity ofBPA in the rat uterotrophic
assaywas not established as part ofthe present
experiments because theirpurposewas to eval-
uate the qualitative activityofthis chemical in
the rat uterotrophic assay. The corresponding
lackofactivityreported for BPA in the imma-
ture CFLP mouse uterotrophic assay (4) is
probably related to its higher toxicity when
subcutaneously injected into mice, as com-
pared to rats. Thus, Coldham et al. (4) only
evaluated two nontoxic dose levels ofBPA (3
and 33 mg/kg BPA), the highest (toxic) dose
evaluated (330 mg/kg) beingbelow the lowest
doselevel used in thepresent ratexperiments.
These data establish the uterotrophic
activity ofBPA to the rat. This information
is relevant to the use of the uterotrophic
assay as a primary screen for endocrine-dis-
rupting chemicals (8). However, the present
data were generated at much higher dose lev-
els than those used to establish other
endocrine toxicities ofBPA, in particular, its
effect on the developing prostate gland of
male CF1 mice (3). Given the many vari-
ables between the present data and the CF1
mouse data (3), it is not possible to relate the
two experimental outcomes quantitatively.
The present data for BPA and DES have
confirmed (8) that prematurevaginal opening
in the immature rat is independent ofactivity
in the uterotrophic assay. In particular, the
similar uterotrophic activity ofBPA using the
sc injection and oral gavage routes ofexposure
is not reflected by the vaginal opening data,
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where only the sc injection route was effec-
tive. This route-specific response may be due
to pharmacodynamic differences of BPA
between different tissues of the rat when
usingthesedifferent routes ofexposure.
Table 1.Activity ofbisphenol A(BPA) in immature ratuterotrophic assays
No.with Mean uterus weight
Study Compound Daily dose Route No. of open (mg)± SD
no. (mg/kg) animals vaginas Wet Dry
1 Arachis oil 5 ml/kg 10 0 27.7 ±7 5.0± 1.0
DES 0.04 PO 5 2 113.2±10.6** 20.0±1.5**
BPA 400 7 0 36.4±8.9* 7.0± 1.0**
BPA 600 7 0 38.1 ± 5.8** 7.0± 1.0**
Arachis oil 5 mI/kg 10 0 30.3± 5.03 6.0± 1.0
DES 0.04 sc 5 1 125.0± 13.2** 21.0± 2.0**
BPA 400 7 0 45.3±8.4** 9.0±2.0**
BPA 600 7 4 51.9± 10.7** 10.0± 2.0**
2 Arachis oil 5 mI/kg sc 10 0 25.4±4.05 Nottaken
BPA 800 8 3 54.5±15.0** Nottaken
3 Arachis oil 5 mI/kg 10 0 29.1 ± 5.2 4.0± 1.0
DES 0.04 PO 5 4 105.4±8.8** 17.0±1.4**
BPA 800 7 0 63.4± 12.8** 10.0± 2.0**
Arachis oil 5ml/kg 10 0 31.9±5.6 6.0± 1.0
DES 0.04 sc 5 2 116.4±15.1** 19.0±1.7**
BPA 800 7 4 64.9 ±12.0** 12.0± 2.2**
SD, standard deviation. Animals were exposed tothe appropriate compound once dailyfor3 consecutive days either via
oral gavage (po) orsubcutaneous injection (sc). Diethylstilbestrol (DES)was used as positive control agent.
*p<0.05;*p<0.01.
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